Primary Study of Suppressive Effect and Mechanism of Resveratrol on Platelet Aggregation

YANG Yu-min,WANG Shi-jun,WANG Hong-qiang,WANG Xin-xiang,CHEN Jun-zhu
DOI: https://doi.org/10.3321/j.issn:1001-2494.2009.03.008
2009-01-01
Abstract:OBJECTIVE To observe the effects and mechanism of Resveratrol (Resv) on adenosine diphosphate (ADP)-induced platelet aggregation. METHODS Platelet aggregometer, flow cytometry and phosphorimaging system were used to study the effects of Resv and protein kinase C inhibitor (PKCI) on the ADP-induced maximal platelet aggregation rate (MPAG), platelet membrane-bound fibrinogen (PFIG), the activity of protein kinase C in membrane of platelets (M-PKC),and the rate of M-PKC in total PKC activity (T-PKC)in healthy volunteers. RESULTS Resv (25,50 and 100 μmol﹒L-1) inhibited ADP-induced MPAG and PFIG in a dose-dependent manner. PKCI and Resv had additive effect in inhibiting MPAG and PFIG. Resv (50 μmol·L-1) obviously depressed M-PKC and M-PKC/T-PKC. CONCLUSION Resv inhibits MPAG and PFIG, which mechanisms may be partly relative to the decrease of the activity of PKC of platelets.
What problem does this paper attempt to address?